Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remogliflozin etabonate dose-ranging study in treatment-naïve type 2 diabetes
NCT00495469Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 2 trial of remogliflozin etabonate in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Aug 2007; status: completed.
02
Drugs
remogliflozin etabonate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00495469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00495469.